Role of Insulin Action in Psoriasis Pathogenesis
Sponsor: Columbia University
Terminated
The study's collaborating dermatologist left the institution, and so skin biopsies could no longer be performed.
Other terminated trials from Columbia University
Other Insulin Resistance trials with similar outcome
This observational or N/A phase trial investigates Insulin Resistance and Overweight and Obesity and is currently terminated or withdrawn. Columbia University leads this study, which shows 8 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Feb 2026 — Present [monthly]
Terminated
Status: Recruiting → Terminated
-
Jan 2026 — Feb 2026 [monthly]
Recruiting
-
Aug 2025 — Jan 2026 [monthly]
Recruiting
-
Jun 2025 — Aug 2025 [monthly]
Recruiting
-
Mar 2025 — Jun 2025 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Sep 2024 — Mar 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Mar 2024 — Jul 2024 [monthly]
Recruiting
First recorded
Feb 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Columbia University
For direct contact, visit the study record on ClinicalTrials.gov .